Ancilia Biosciences, Inc.

Form D Filings

Location
New York, NY
Industry Group
Other
Entity Type
Corporation
CIK
0001975776
All SEC Filings
View on sec.gov
Date Filed Security Types Total Amount Sold Total Offering Amount Remaining First Sale Signed Form SEC Link
4/6/2026 Equity $10,076,464 $10,076,464 $0 2/13/2026 4/6/2026 D 000197577626000006
5/4/2023 Debt $1,000,000 $5,000,000 $4,000,000 4/13/2023 5/4/2023 D 000197577623000001